Multiomics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity
| dc.contributor.author | Ambikan, Anoop T. | |
| dc.contributor.author | Yang, Hong | |
| dc.contributor.author | Krishnan, Shuba | |
| dc.contributor.author | Svensson Akusjärvi, Sara | |
| dc.contributor.author | Gupta, Soham | |
| dc.contributor.author | Lourda, Magda | |
| dc.contributor.author | Sperk, Maike | |
| dc.contributor.author | Arif, Muhammad | |
| dc.contributor.author | Zhang, Cheng | |
| dc.contributor.author | Nordqvist, Hampus | |
| dc.contributor.author | Ponnan, Sivasankaran Munusamy | |
| dc.contributor.author | Sönnerborg, Anders | |
| dc.contributor.author | Treutiger, Carl Johan | |
| dc.contributor.author | O'Mahony, Liam | |
| dc.contributor.author | Mardinoglu, Adil | |
| dc.contributor.author | Benfeitas, Rui | |
| dc.contributor.author | Neogi, Ujjwal | |
| dc.contributor.funder | Vetenskapsrådet | en |
| dc.contributor.funder | Karolinska Institutet | en |
| dc.contributor.funder | Center for Medical Innovation | en |
| dc.contributor.funder | Åke Wiberg Stiftelse | en |
| dc.date.accessioned | 2022-07-12T15:02:51Z | |
| dc.date.available | 2022-07-12T15:02:51Z | |
| dc.date.issued | 2022-07-08 | |
| dc.date.updated | 2022-07-12T14:31:33Z | |
| dc.description.abstract | The clinical outcome and disease severity in coronavirus disease-2019 (COVID-19) are heterogeneous, and the progression or fatality of the disease cannot be explained by a single factor like age or comorbidities. In this study, we used system-wide network-based system biology analysis using whole blood RNA sequencing, immune-phenotyping by flow cytometry, plasma metabolomics, and single cell-type metabolomics of the monocytes to identify the potential determinants of COVID-19 severity at the personalized and group level. Digital cell quantification and immune-phenotyping of the mononuclear phagocytes indicated a substantial role in coordinating the immune cells that mediate the COVID-19 severity. Stratum-specific and personalized genome-scale metabolic modeling indicated monocarboxylate transporter family genes (e.g., SLC16A6), nucleoside transporter genes (e.g., SLC29A1), and metabolites such as α-ketoglutarate, succinate, malate, and butyrate, could play a crucial role in COVID-19 severity. Metabolic perturbations targeting the central metabolic pathway (TCA-cycle) can be an alternate treatment strategy in severe COVID-19. | en |
| dc.description.sponsorship | Vetenskapsrådet (grants 2021-00993; 2017-01330; 2018-06156; 2021-03035) Karolinska Institutet (grant 2020-01554; 2020-02153); Center for Medical Innovation (grant CIMED-FoUI-093304); Åke Wiberg Stiftelse (grant M20-0220) | en |
| dc.description.status | Peer reviewed | en |
| dc.description.version | Accepted Version | en |
| dc.format.mimetype | application/pdf | en |
| dc.identifier.citation | Ambikan, A. T., Krishnan, S., Yang, H., Svensson Akusjärvi, S., Gupta, S., Lourda, M., Sperk, M., Arif, M., Zhang, C., Nordqvist, H., Ponnan, S. M., Sönnerborg, A., Treutiger, C. J., O’Mahony, L., Mardinoglu, A., Benfeitas, R. and Neogi, U. (2022) 'Multiomics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity', Cell Systems, 13(8), pp.665-681. https://doi.org/10.1016/j.cels.2022.06.006 | en |
| dc.identifier.doi | 10.1016/j.cels.2022.06.006 | en |
| dc.identifier.eissn | 2405-4712 | |
| dc.identifier.endpage | 681 | |
| dc.identifier.issued | 8 | |
| dc.identifier.journaltitle | Cell Systems | en |
| dc.identifier.startpage | 665 | |
| dc.identifier.uri | https://hdl.handle.net/10468/13358 | |
| dc.identifier.volume | 13 | |
| dc.language.iso | en | en |
| dc.publisher | Elsevier B.V. | en |
| dc.rights | © 2021, Elsevier B.V. All rights reserved. This manuscript version is made available under the CC BY-NC-ND 4.0 license. | en |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | en |
| dc.subject | Multiomics personalized network analyses | en |
| dc.subject | Progressive disruption | en |
| dc.subject | Central metabolism | en |
| dc.subject | COVID-19 | en |
| dc.subject | Severity | en |
| dc.title | Multiomics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity | en |
| dc.type | Article (peer-reviewed) | en |
